Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 292
Selected: 0
NCT IDTitle
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT01610700An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
NCT02150928An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
NCT05244239Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
NCT03825796CPX-351 Plus Enasidenib for Relapsed AML
NCT05260528CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
NCT00132873Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
NCT04133480Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
NCT01322139Sativex Thorough QT/QTc Study
NCT01887301Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
NCT06143839VYxeoS Liposomal Italian Observational Study iN the Real Practice
NCT01606202A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
NCT04541082Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
NCT02238925An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients
NCT01337089Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
NCT06108050JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
NCT05178316A Study of JZP150 in Adults With Posttraumatic Stress Disorder
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT04984278Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
NCT02348606"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
NCT00498485Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
NCT04899947Child and Adolescent Registry for Participants With Narcolepsy
NCT02269579Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment
NCT02369471A Study of GWP42006 in People With Focal Seizures - Part A
NCT04268966An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola
NCT05557045A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
NCT04389840Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
NCT05574504Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
NCT06217536Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas
NCT01681121A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
NCT00788892Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
NCT01610687A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT04203498Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
NCT00590915Erwinase Master Treatment Protocol
NCT05485831Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT06012929A Study of ONC201 for Refractory Meningioma
NCT01643408A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
NCT01812603A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma
NCT02073474An Observational Post-Marketing Safety Registry of Sativex®
NCT05229588Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
NCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
NCT04176042Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea
NCT07778810Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
NCT02806908Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
NCT00678795A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
NCT04571645Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
NCT03436953A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
NCT05476939Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0